=== OFFICIAL TITLE ===
To extend the National Alzheimer's Project.

=== STRUCTURED BODY ===
    1.
    Header: Short title
    This Act may be cited as the
        NAPA Reauthorization Act
    .
    2.
    Header: Extension of project
    Section 2 of the National Alzheimer's Project Act (
      42 U.S.C. 11225
    ) is amended—
      (1)
      in subsection (c)—
        (A)
        in paragraph (2), by striking
          and coordination of
        and inserting
          on, and coordination of,
        ;
        (B)
        in paragraph (4)—
          (i)
          by redesignating subparagraphs (A) and (B) as subparagraphs (B) and (C), respectively; and
          (ii)
          by inserting before subparagraph (B), as so redesignated, the following:
              (A)
              promotion of healthy aging and reduction and mitigation of risk factors for Alzheimer's;
            ;
        (C)
        in paragraph (5)—
          (i)
          by inserting
            and other underserved populations, including individuals with developmental disabilities such as Down syndrome,
          after
            populations
          ; and
          (ii)
          by striking
            ; and
          and inserting a semicolon;
        (D)
        by redesignating paragraph (6) as paragraph (7); and
        (E)
        by inserting after paragraph (5) the following:
            (6)
            provide information on, and promote the adoption of, healthy behaviors that may reduce the risk of cognitive decline and promote and protect cognitive health; and
          ;
      (2)
      in subsection (d)(2)—
        (A)
        by inserting
          , across public and private sectors,
        after
          Nation's progress
        ; and
        (B)
        by inserting
          , including consideration of public-private collaborations, as appropriate
        before the period;
      (3)
      in subsection (e)—
        (A)
        in paragraph (2)—
          (i)
          in subparagraph (A), by adding at the end the following:
              (xi)
              A designee of the Department of Justice.
              (xii)
              A designee of the Federal Emergency Management Agency.
              (xiii)
              A designee of the Social Security Administration.
              (xiv)
              2 or more other designees, as determined by the Secretary of Health and Human Services, at least one of whom has expertise in risk factors associated with the development or the progression of Alzheimer's.
            ; and
          (ii)
          in subparagraph (B)—
            (I)
            in the matter preceding clause (i), by striking
              12
            and inserting
              15
            ;
            (II)
            in clause (v)—
              (aa)
              by striking
                2 researchers
              and inserting
                3 researchers
              ; and
              (bb)
              by striking
                ; and
              and inserting
                , including at least one researcher with demonstrated experience in recruitment and retention of underrepresented groups into research or clinical trials related to dementia;
              ;
            (III)
            in clause (vi), by striking the period and inserting a semicolon; and
            (IV)
            by adding at the end the following:
                (vii)
                1 individual with a diagnosis of Alzheimer's disease; and
                (viii)
                1 representative from a historically underserved population whose lifetime risk for developing Alzheimer's is markedly higher than that of other populations.
              ;
        (B)
        in paragraph (5)—
          (i)
          in subparagraph (A)—
            (I)
            by striking
              an initial evaluation
            and inserting
              annual evaluations
            ; and
            (II)
            by striking
              research, clinical
            and inserting
              research, risk reduction, public health, clinical
            ;
          (ii)
          in subparagraph (B), by striking
            initial
          ;
          (iii)
          in subparagraph (C)—
            (I)
            in the matter preceding clause (i), by striking
              initial
            ; and
            (II)
            in clause (ii), by inserting
              and reduce disparities
            before the semicolon; and
          (iv)
          in subparagraph (D), by striking
            annually thereafter, an evaluation
          and inserting
            annual evaluations
          ; and
        (C)
        in paragraph (6), by striking
          2025
        and inserting
          2035
        ;
      (4)
      in subsection (g)—
        (A)
        in paragraph (1)—
          (i)
          by adding
            and
          after the semicolon;
          (ii)
          by striking
            that includes an evaluation
          and inserting “that includes—
              (A)
              an evaluation;
            ; and
          (iii)
          by adding at the end the following:
              (B)
              a summary of the Secretary's process for identifying and updating what conditions constitute Alzheimer's disease;
            ; and
        (B)
        in paragraph (3)(A)(ii), by inserting
          and reduce disparities
        before the semicolon; and
      (5)
      in subsection (h), by striking
        2025
      and inserting
        2035
      .
